Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-07-03
1989-05-16
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548453, C07D48704, A61K 31395
Patent
active
048310492
ABSTRACT:
A novel pyrrolizidine compound of the formula ##STR1## wherein R.sup.1 is an alkyl group of 1 to 4 carbon atoms or a phenyl group; and R.sup.2 and R.sup.3 are such that at least one of them is an alkyl group of 1 to 4 carbon atoms and the other, if not alkyl, being a hydrogen atom is produced by reacting .DELTA..sup.4(8) -dehydropyrrolizidine with a substituted malonic acid and the thus formed 2-substituted-8-pyrrolizidineacetic acid with a substituted aniline. The products are subjected to optical resolution and are potentantiarrhythmic agents.
REFERENCES:
patent: 4020094 (1977-04-01), Nelson et al.
patent: 4564624 (1986-01-01), Miyano et al.
patent: 4617401 (1986-10-01), Miyano et al.
Miyano Seiji
Satoh Fumio
Sumoto Kunihiro
Springer David B.
Suntory Limited
LandOfFree
Pyrrolizidine compounds, and their use as antiarrhythmic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolizidine compounds, and their use as antiarrhythmic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolizidine compounds, and their use as antiarrhythmic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322894